Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo

Brain Research

Volumn 891, Issue 1-2, 2001, Pages 218-227

  Burke, William J ^a,b   Li, Shu Wen ^a   Zahm, Daniel S ^b   Macarthur, Heather ^a   Kolo, Lacy L ^a   Westfall, Thomas C ^a   Anwar, Muhammad ^c   Glickstein, Sara B ^c,d   Ruggiero, David A ^c,d  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Anatomy and Neurobiology ^*  (United States)

^c Departments of Anatomy and Cell Biology and Psychiatry ^*  (United States)

^d Neurological Research Institute of Lubec   (United States)

Author keywords

3,4 dihydroxyphenylglycolaldehyde; Adrenergic neurons; Alzheimer's disease; Apoptosis

Indexed keywords

3,4 DIHYDROXYPHENYLGLYCOALDEHYDE; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ADRENALIN; ALDEHYDE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOLAMINE; DNA NUCLEOTIDYLEXOTRANSFERASE; NEUROTOXIN; NEUROTRANSMITTER; NORADRENALIN; PHENYLETHANOLAMINE N METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADRENERGIC NERVE CELL; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; DOSE RESPONSE; GLIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ALDEHYDES; ANIMALS; APOPTOSIS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLA OBLONGATA; NERVE DEGENERATION; NEURONS; NEUROTOXINS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; RETICULAR FORMATION;

EID: 0035830773     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03199-1     Document Type: Article

References (44)

1. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
2. Catecholaminergic neurons in the ventrolateral medulla and nucleus of the solitary tract in the human
3. Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
4. Amine oxidase and amine metabolism
5. Cerebral hypoxia
6. Evidence for decreased transport of PNMT protein in advanced Alzheimer's disease
7. Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease
8. Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells
9. Norepinephrine transmitter metabolite induces apoptosis in differentiated rat pheochromocytoma cells
10. Norepinephrine transmitter metabolite generates free radicals and activates mitochondrial permeability transition: A mechanism for DOPEGAL induced apoptosis
11. Quantitation of 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde, the monoamine oxidase metabolites of dopamine and noradrenaline, in human tissues by microcolumn high-performance liquid chromatography
12. Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: Mechanism of neuron death
13. Catecholamine-derived aldehyde neurotoxins
14. Modulation of intracellular calcium transients and dopamine release by neuropeptide Y in PC 12 cells
15. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement
16. Assay of cell viability: Discrimination of cells dying by apoptosis
17. Effect of differentiation on neuropeptide Y receptors and responses in rat pheochromocytoma cells
18. Missense and silent tau mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type by affecting multiple alternative RNA splicing regulatory elements
19. Involvement of a caspase-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured granule neurons
20. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A HMRS study
21. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastitial injection
22. Levodopa-induced neurotoxicity
23. Loss of C-1 and C-3 epinephrine-synthesizing neurons in medulla oblongata in Parkinson's disease
24. Complex I inhibitors induce dose-dependent apoptosis in PC 12 cells: Relevance to Parkinson's disease
25. Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain
26. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
27. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
28. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
29. Synthesis of a biochemically important aldehyde, 3,4-dihydroxyphenylglycolaldehyde as an internal standard for determination of DOPEGAL in brain tissue by gas chromatography-mass spectrometry
30. Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen
31. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture
32. Does selegeline monotherapy in parkinson's disease act by symptomatic or protective mechanisms
33. Diseases of the basal ganglia, cerebellum and motor neurons
34. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
35. Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity
36. Distribution of neurons containing phenylethanolamine N-methyltransferase in medulla and hypothalamus of rat
37. Newly identified GABAergic neurons in regions of the ventrolateral medulla which regulate blood pressure
38. Adrenergic and non-adrenergic spinal projections of a cardiovascular-active pressor area of medulla oblongata: Quantitative topographic analysis
39. 3H-thymidine-labelled cells prior to autoradiography
40. Release of apoptogenic proteins from mitochondrial intermembrane space during mitochondrial permeability transition
41. Biochemical events in the development of Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
42. Baroreflex actions of substance P microinjected into nucleus stratus solitarii in rat: A consequence of local distortion
43. Mechanism of lipid peroxidation potentiated by ischemia in brain
44. Antioxidant defense of the brain: A role for astrocytes